1. Home
  2. BFST vs MBX Comparison

BFST vs MBX Comparison

Compare BFST & MBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFST
  • MBX
  • Stock Information
  • Founded
  • BFST 2006
  • MBX 36
  • Country
  • BFST United States
  • MBX United States
  • Employees
  • BFST N/A
  • MBX N/A
  • Industry
  • BFST Major Banks
  • MBX
  • Sector
  • BFST Finance
  • MBX
  • Exchange
  • BFST Nasdaq
  • MBX NYSE
  • Market Cap
  • BFST 716.6M
  • MBX 762.6M
  • IPO Year
  • BFST 2018
  • MBX 2024
  • Fundamental
  • Price
  • BFST $27.95
  • MBX $16.51
  • Analyst Decision
  • BFST Buy
  • MBX Strong Buy
  • Analyst Count
  • BFST 2
  • MBX 4
  • Target Price
  • BFST $26.00
  • MBX $37.25
  • AVG Volume (30 Days)
  • BFST 105.9K
  • MBX 98.7K
  • Earning Date
  • BFST 10-24-2024
  • MBX 11-07-2024
  • Dividend Yield
  • BFST 1.99%
  • MBX N/A
  • EPS Growth
  • BFST N/A
  • MBX N/A
  • EPS
  • BFST 2.32
  • MBX N/A
  • Revenue
  • BFST $249,883,000.00
  • MBX N/A
  • Revenue This Year
  • BFST N/A
  • MBX N/A
  • Revenue Next Year
  • BFST $18.49
  • MBX N/A
  • P/E Ratio
  • BFST $12.12
  • MBX N/A
  • Revenue Growth
  • BFST 1.14
  • MBX N/A
  • 52 Week Low
  • BFST $18.97
  • MBX $15.31
  • 52 Week High
  • BFST $30.30
  • MBX $27.50
  • Technical
  • Relative Strength Index (RSI)
  • BFST 54.59
  • MBX N/A
  • Support Level
  • BFST $25.13
  • MBX N/A
  • Resistance Level
  • BFST $29.27
  • MBX N/A
  • Average True Range (ATR)
  • BFST 1.19
  • MBX 0.00
  • MACD
  • BFST -0.14
  • MBX 0.00
  • Stochastic Oscillator
  • BFST 54.58
  • MBX 0.00

About BFST Business First Bancshares Inc.

Business First Bancshares Inc is a United States-based bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

Share on Social Networks: